{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:42:16Z","timestamp":1791477736301,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10198-021-01328-7","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T08:02:32Z","timestamp":1624003352000},"page":"1151-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The economic burden of amyotrophic lateral sclerosis: a systematic review"],"prefix":"10.1007","volume":"22","author":[{"given":"K.","family":"Achtert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kerkemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cogsys.2018.09.012","volume":"52","author":"MP Schlaile","year":"2018","unstructured":"Schlaile, M.P., Knausberg, T., Mueller, M., Zeman, J.: Viral ice buckets: a memetic perspective on the ALS Ice Bucket Challenge\u2019s diffusion. Cogn. Syst. Res. 52, 947\u2013969 (2018)","journal-title":"Cogn. Syst. Res."},{"issue":"2","key":"1328_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R.H., Al-Chalabi, A.: Amyotrophic lateral sclerosis. N Engl J Med 377(2), 162\u2013172 (2017). https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"issue":"12","key":"1328_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00115-007-2354-5","volume":"78","author":"R Gastl","year":"2007","unstructured":"Gastl, R., Ludolph, A.C.: Amyotrophic lateral sclerosis. Nervenarzt 78(12), 1449\u20131457 (2007). https:\/\/doi.org\/10.1007\/s00115-007-2354-5. (quiz 1458-1449)","journal-title":"Nervenarzt"},{"issue":"2","key":"1328_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24096","volume":"75","author":"E Pupillo","year":"2014","unstructured":"Pupillo, E., Messina, P., Logroscino, G., Beghi, E., S Group: Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75(2), 287\u2013297 (2014). https:\/\/doi.org\/10.1002\/ana.24096","journal-title":"Ann Neurol"},{"issue":"11\u201312","key":"1328_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbadis.2006.09.008","volume":"1762","author":"E Beghi","year":"2006","unstructured":"Beghi, E., Logroscino, G., Chio, A., Hardiman, O., Mitchell, D., Swingler, R., Traynor, B.J.: The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762(11\u201312), 1150\u20131157 (2006). https:\/\/doi.org\/10.1016\/j.bbadis.2006.09.008. (Epub 2006 Sep 29)","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1328_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","volume":"79","author":"G Logroscino","year":"2008","unstructured":"Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Couratier, P., Mitchell, J.D., Swingler, R.J., Beghi, E.: Eurals: descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79(1), 6\u201311 (2008). https:\/\/doi.org\/10.1136\/jnnp.2006.104828","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1328_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","volume":"81","author":"G Logroscino","year":"2010","unstructured":"Logroscino, G., Traynor, B.J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R.J., Millul, A., Benn, E., Beghi, E.: Eurals: Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81(4), 385\u2013390 (2010). https:\/\/doi.org\/10.1136\/jnnp.2009.183525","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1328_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/jnnp.55.12.1106","volume":"55","author":"AM Chancellor","year":"1992","unstructured":"Chancellor, A.M., Warlow, C.P.: Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 55(12), 1106\u20131115 (1992). https:\/\/doi.org\/10.1136\/jnnp.55.12.1106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1328_CR9","volume-title":"Motoneuronenerkrankungen","year":"2011","unstructured":"Ludolph, A. (ed.): Motoneuronenerkrankungen, 3rd edn. Springer, Berlin (2011)","edition":"3"},{"issue":"2","key":"1328_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chio","year":"2013","unstructured":"Chio, A., Logroscino, G., Traynor, B.J., Collins, J., Simeone, J.C., Goldstein, L.A., White, L.A.: Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41(2), 118\u2013130 (2013). https:\/\/doi.org\/10.1159\/000351153. (Epub 2013 Jul 11)","journal-title":"Neuroepidemiology"},{"key":"1328_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510x(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks, B.R.: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical limits of amyotrophic lateral sclerosis\u201d workshop contributors. J Neurol Sci 124, 96\u2013107 (1994). https:\/\/doi.org\/10.1016\/0022-510x(94)90191-0","journal-title":"J Neurol Sci"},{"key":"1328_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1172-4-3","volume":"4","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera, L.C., Leigh, P.N.: Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4, 3 (2009). https:\/\/doi.org\/10.1186\/1750-1172-4-3","journal-title":"Orphanet J Rare Dis"},{"key":"1328_CR13","doi-asserted-by":"publisher","unstructured":"Miller, R.G., Mitchell, J.D., Moore, D.H.: Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst. Rev. (3), CD001447 (2012). https:\/\/doi.org\/10.1002\/14651858.CD001447.pub3","DOI":"10.1002\/14651858.CD001447.pub3"},{"issue":"7\u20138","key":"1328_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/21678421.2017.1369125","volume":"18","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi, A., Andersen, P.M., Chandran, S., Chio, A., Corcia, P., Couratier, P., Danielsson, O., de Carvalho, M., Desnuelle, C., Grehl, T., Grosskreutz, J., Holmoy, T., Ingre, C., Karlsborg, M., Kleveland, G., Koch, J.C., Koritnik, B., KuzmaKozakiewicz, M., Laaksovirta, H., Ludolph, A., McDermott, C., Meyer, T., Mitre Ropero, B., Mora Pardina, J., Nygren, I., Petri, S., Povedano Panades, M., Salachas, F., Shaw, P., Silani, V., Staaf, G., Svenstrup, K., Talbot, K., Tysnes, O.B., Van Damme, P., van der Kooi, A., Weber, M., Weydt, P., Wolf, J., Hardiman, O., van den Berg, L.H.: July 2017 ENCALS statement on edaravone. Amyotroph Lateral Scler Frontotemporal Degener 18(7\u20138), 471\u2013474 (2017). https:\/\/doi.org\/10.1080\/21678421.2017.1369125. (Epub 2017 Oct 4)","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"1328_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5405\/jmbe.836","volume":"32","author":"SS Liu","year":"2012","unstructured":"Liu, S.S., Rawicz, A., Rezael, S., Ma, T., Zhang, C., Lin, K.: An eye-Gaze tracking and human computer interface system for people with ALS and other locked-in diseases. J Med Biol Eng 32(2), 111\u2013116 (2012)","journal-title":"J Med Biol Eng"},{"issue":"6","key":"1328_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00019053-200220060-00002","volume":"20","author":"G Ginsberg","year":"2002","unstructured":"Ginsberg, G., Lowe, S.: Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature. Pharmacoeconomics 20(6), 367\u2013387 (2002). https:\/\/doi.org\/10.2165\/00019053-200220060-00002","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"1328_CR17","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00415-017-8632-7","volume":"264","author":"R Wynford-Thomas","year":"2017","unstructured":"Wynford-Thomas, R., Robertson, N.P.: The economic burden of chronic neurological disease. J Neurol 264(11), 2345\u20132347 (2017). https:\/\/doi.org\/10.1007\/s00415-017-8632-7","journal-title":"J Neurol"},{"key":"1328_CR18","unstructured":"World Health Oranisation: Neurological disorders - public health challenges. https:\/\/www.who.int\/mental_health\/neurology\/introduction_neuro_disorders_public_h_challenges.pdf?ua=1 (2006). Accessed June 2020"},{"issue":"3\u20134","key":"1328_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/21678421.2017.1408126","volume":"19","author":"G Fiorentino","year":"2018","unstructured":"Fiorentino, G., Esquinas, A.M.: Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending. Amyotroph Lateral Scler Frontotemporal Degener 19(3\u20134), 315\u2013316 (2018). https:\/\/doi.org\/10.1080\/21678421.2017.1408126. (Epub 2017 Nov 30)","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"1328_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1586\/14737167.2015.1039941","volume":"15","author":"M Gladman","year":"2015","unstructured":"Gladman, M., Zinman, L.: The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res 15(3), 439\u2013450 (2015). https:\/\/doi.org\/10.1586\/14737167.2015.1039941. (Epub 2015 Apr 30)","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10","key":"1328_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., P Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10), 1006\u20131012 (2009). https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005. (Epub 2009 Jul 23)","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"1328_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10), e1-34 (2009). https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006. (Epub 2009 Jul 23)","journal-title":"J Clin Epidemiol"},{"key":"1328_CR23","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., Welch, V.A.: Cochrane Handbook for systematic reviews of interventions version 6.0 (updated July 2019) (2019)","DOI":"10.1002\/9781119536604"},{"key":"1328_CR24","unstructured":"Kassen\u00e4rztliche Bundesvereinigung: Online-Version des EBM. https:\/\/www.kbv.de\/html\/online-ebm.php (2020). Accessed June 2020"},{"key":"1328_CR25","unstructured":"Oecd: Purchasing Power Parties (PPP) (2020). https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. Accessed June 2020"},{"key":"1328_CR26","unstructured":"Statistisches, B.: Harmonisierter Verbraucherpreisindex (2020). https:\/\/www.destatis.de\/DE\/ZahlenFakten\/Gesamtwirtschaft-Umwelt\/Preise\/Verbraucherpreisindizes\/Tabellen_\/HarmonisierterVerbraucherpreisindex.tml?cms_gtp=146598_slot%253D2. Accessed June 2020"},{"issue":"7052","key":"1328_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","volume":"313","author":"MF Drummond","year":"1996","unstructured":"Drummond, M.F., Jefferson, T.O.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party. BMJ 313(7052), 275\u2013283 (1996). https:\/\/doi.org\/10.1136\/bmj.313.7052.275","journal-title":"BMJ"},{"issue":"7","key":"1328_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson, T.R., Acs, A., Ludwig, C., Panton, U.H.: Economic burden of cardiovascular disease in Type 2 diabetes: a systematic review. Value. Health. 21(7), 881\u2013890 (2018). https:\/\/doi.org\/10.1016\/j.jval.2017.12.019. (Epub 2018 Feb 16)","journal-title":"Value. Health."},{"issue":"5","key":"1328_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1467-789X.2011.00968.x","volume":"13","author":"F Pelone","year":"2012","unstructured":"Pelone, F., Specchia, M.L., Veneziano, M.A., Capizzi, S., Bucci, S., Mancuso, A., Ricciardi, W., de Belvis, A.G.: Economic impact of childhood obesity on health systems: a systematic review. Obes. Rev. 13(5), 431\u2013440 (2012). https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00968.x. (Epub 2011 Dec 29)","journal-title":"Obes. Rev."},{"key":"1328_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-9-24","volume":"9","author":"K Bahadori","year":"2009","unstructured":"Bahadori, K., Doyle-Waters, M.M., Marra, C., Lynd, L., Alasaly, K., Swiston, J., FitzGerald, J.M.: Economic burden of asthma: a systematic review. BMC. Pulm. Med. 9, 24 (2009). https:\/\/doi.org\/10.1186\/1471-2466-9-24","journal-title":"BMC. Pulm. Med."},{"issue":"6","key":"1328_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/1471-0528.12241","volume":"120","author":"D Husereau","year":"2013","unstructured":"Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J., Loder, E., Force, C.T.: Consolidated health economic evaluation reporting standards (CHEERS) statement. BJOG. 120(6), 765\u2013770 (2013). https:\/\/doi.org\/10.1111\/1471-0528.12241","journal-title":"BJOG."},{"issue":"2","key":"1328_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S0266462305050324","volume":"21","author":"S Evers","year":"2005","unstructured":"Evers, S., Goossens, M., de Vet, H., van Tulder, M., Ament, A.: Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria. Int. J. Technol. Assess. Health. Care. 21(2), 240\u2013245 (2005)","journal-title":"Int. J. Technol. Assess. Health. Care."},{"issue":"4","key":"1328_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., Vist, G.E., Falck-Ytter, Y., Meerpohl, J., Norris, S., Guyatt, G.H.: GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 64(4), 401\u2013406 (2011). https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015. (Epub 2011 Jan 5)","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"1328_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/17482960802103131","volume":"10","author":"I van der Steen","year":"2009","unstructured":"van der Steen, I., van den Berg, J.P., Buskens, E., Lindeman, E., van den Berg, L.H.: The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph. Lateral. Scler. 10(1), 27\u201334 (2009). https:\/\/doi.org\/10.1080\/17482960802103131","journal-title":"Amyotroph. Lateral. Scler."},{"issue":"1\u20132","key":"1328_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/21678421.2014.932384","volume":"16","author":"K Athanasakis","year":"2015","unstructured":"Athanasakis, K., Kyriopoulos, I.I., Sideris, M., Rentzos, M., Evdokimidis, J., Kyriopoulos, J.: Investigating the economic burden of ALS in Greece: a cost-of-illness approach. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 16(1\u20132), 63\u201364 (2015). https:\/\/doi.org\/10.3109\/21678421.2014.932384. (Epub 2014 Jul 14)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"issue":"3","key":"1328_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00415-012-6706-0","volume":"260","author":"P Jennum","year":"2013","unstructured":"Jennum, P., Ibsen, R., Pedersen, S.W., Kjellberg, J.: Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. J. Neurol. 260(3), 785\u2013793 (2013). https:\/\/doi.org\/10.1007\/s00415-012-6706-0. (Epub 2012 Oct 27)","journal-title":"J. Neurol."},{"issue":"3","key":"1328_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.23942","volume":"49","author":"J Larkindale","year":"2014","unstructured":"Larkindale, J., Yang, W., Hogan, P.F., Simon, C.J., Zhang, Y., Jain, A., Habeeb-Louks, E.M., Kennedy, A., Cwik, V.A.: Cost of illness for neuromuscular diseases in the United States. Muscle. Nerve. 49(3), 431\u2013438 (2014). https:\/\/doi.org\/10.1002\/mus.23942. (Epub 2014 Jan 28)","journal-title":"Muscle. Nerve."},{"key":"1328_CR38","unstructured":"Muscular Dystrophy, A.: Cost of amyotrophic lateral sclerosis, muscular dystrophy, and spinal muscular atrophy in the United States  (2012). https:\/\/www.mda.org\/sites\/default\/files\/Cost_Illness_Report_0.pdf"},{"issue":"4","key":"1328_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/17482960802430781","volume":"10","author":"J Lopez-Bastida","year":"2009","unstructured":"Lopez-Bastida, J., Perestelo-Perez, L., Monton-Alvarez, F., Serrano-Aguilar, P., Alfonso-Sanchez, J.L.: Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph. Lateral. Scler. 10(4), 237\u2013243 (2009). https:\/\/doi.org\/10.1080\/17482960802430781","journal-title":"Amyotroph. Lateral. Scler."},{"issue":"3\u20134","key":"1328_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/21678421.2014.999791","volume":"16","author":"J Oh","year":"2015","unstructured":"Oh, J., An, J.W., Oh, S.I., Oh, K.W., Kim, J.A., Lee, J.S., Kim, S.H.: Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 16(3\u20134), 202\u2013208 (2015). https:\/\/doi.org\/10.3109\/21678421.2014.999791. (Epub 2015 Feb 3)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"issue":"1","key":"1328_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00415-009-5256-6","volume":"257","author":"K Schepelmann","year":"2010","unstructured":"Schepelmann, K., Winter, Y., Spottke, A.E., Claus, D., Grothe, C., Schroder, R., Heuss, D., Vielhaber, S., Mylius, V., Kiefer, R., Schrank, B., Oertel, W.H., Dodel, R.: Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. 257(1), 15\u201323 (2010). https:\/\/doi.org\/10.1007\/s00415-009-5256-6. (Epub 2009 Jul 24)","journal-title":"J. Neurol."},{"issue":"1","key":"1328_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-020-01413-9","volume":"15","author":"E Schonfelder","year":"2020","unstructured":"Schonfelder, E., Osmanovic, A., Muschen, L.H., Petri, S., Schreiber-Katz, O.: Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany. Orphanet. J. Rare. Dis. 15(1), 149 (2020). https:\/\/doi.org\/10.1186\/s13023-020-01413-9","journal-title":"Orphanet. J. Rare. Dis."},{"key":"1328_CR43","unstructured":"Deloitte Access Economics: Economics analysis of motor neurone disease in Australia\u2013Report for Motor Neurone Disease Australia (2015). https:\/\/www2.deloitte.com\/au\/en\/pages\/economics\/articles\/economic-analysis-motor-neurone-disease-australia.html"},{"issue":"1\u20132","key":"1328_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/21678421.2014.957322","volume":"16","author":"S Connolly","year":"2015","unstructured":"Connolly, S., Heslin, C., Mays, I., Corr, B., Normand, C., Hardiman, O.: Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 16(1\u20132), 58\u201362 (2015). https:\/\/doi.org\/10.3109\/21678421.2014.957322. (Epub 2014 Oct 6)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"issue":"5\u20136","key":"1328_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3109\/21678421.2014.932382","volume":"15","author":"M Gladman","year":"2014","unstructured":"Gladman, M., Dharamshi, C., Zinman, L.: Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 15(5\u20136), 426\u2013432 (2014). https:\/\/doi.org\/10.3109\/21678421.2014.932382. (Epub 2014 Jul 15)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"key":"1328_CR46","doi-asserted-by":"publisher","unstructured":"Lopes de Almeida, J.P., Pinto, A., Pinto, S., Ohana, B., de Carvalho, M.: Economic cost of home-telemonitoring care for BiPAP-assisted ALS individuals. Amyotroph Lateral Scler. 13(6), 533\u2013537 (2012). https:\/\/doi.org\/10.3109\/17482968.2012.703675. (Epub 2012 Aug 8)","DOI":"10.3109\/17482968.2012.703675"},{"issue":"1\u20132","key":"1328_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/21678421.2017.1363242","volume":"19","author":"L Meng","year":"2018","unstructured":"Meng, L., Bian, A., Jordan, S., Wolff, A., Shefner, J.M., Andrews, J.: Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 19(1\u20132), 134\u2013142 (2018). https:\/\/doi.org\/10.1080\/21678421.2017.1363242. (Epub 2017 Sep 11)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"key":"1328_CR48","doi-asserted-by":"publisher","first-page":"613596","DOI":"10.1155\/2013\/613596","volume":"2013","author":"W Pan","year":"2013","unstructured":"Pan, W., Chen, X., Bao, J., Bai, Y., Lu, H., Wang, Q., Liu, Y., Yuan, C., Li, W., Liu, Z., Liu, J., Zhu, X., Qin, B., Cai, D., Zhou, H.: The use of integrative therapies in patients with amyotrophic lateral sclerosis in shanghai, china. Evid. Based. Complement. Alternat. Med. 2013, 613596 (2013). https:\/\/doi.org\/10.1155\/2013\/613596. (Epub 2013 Dec 2)","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"1328_CR49","unstructured":"Canadian Institute for Health, I.: The burden of neurological diseases, disorders and injuries in Canada (2007). https:\/\/secure.cihi.ca\/free_products\/BND_e.pdf"},{"issue":"1","key":"1328_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10834-009-9177-4","volume":"31","author":"MP McCabe","year":"2010","unstructured":"McCabe, M.P., O\u2019Connor, E.J.: The Economic impact of progressive neurological ilness on quality of Lige in Australia. J. Fam. Econ. Issues 31(1), 82\u201389 (2010)","journal-title":"J. Fam. Econ. Issues"},{"issue":"10","key":"1328_CR51","doi-asserted-by":"publisher","first-page":"e0223772","DOI":"10.1371\/journal.pone.0223772","volume":"14","author":"J Darba","year":"2019","unstructured":"Darba, J.: Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: a population-based analysis. PLoS One 14(10), e0223772 (2019). https:\/\/doi.org\/10.1371\/journal.pone.0223772","journal-title":"PLoS One"},{"issue":"11","key":"1328_CR52","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jval.2019.05.011","volume":"22","author":"A Moore","year":"2019","unstructured":"Moore, A., Young, C.A., Hughes, D.A.: Health utilities and costs for motor neurone disease. Value. Health. 22(11), 1257\u20131265 (2019). https:\/\/doi.org\/10.1016\/j.jval.2019.05.011","journal-title":"Value. Health."},{"issue":"23","key":"1328_CR53","doi-asserted-by":"publisher","first-page":"e2083","DOI":"10.1212\/WNL.0000000000008582","volume":"93","author":"J Zwicker","year":"2019","unstructured":"Zwicker, J., Qureshi, D., Talarico, R., Bourque, P., Scott, M., Chin-Yee, N., Tanuseputro, P.: Dying of amyotrophic lateral sclerosis: health care use and cost in the last year of life. Neurology 93(23), e2083\u2013e2093 (2019). https:\/\/doi.org\/10.1212\/WNL.0000000000008582","journal-title":"Neurology"},{"issue":"5","key":"1328_CR54","first-page":"e1","volume":"108","author":"L Wagner","year":"2012","unstructured":"Wagner, L., Archer, N.P., Williamson, D.M., Henry, J.P., Schiffer, R., Jackson, C.E.: Prevalence of amyotrophic lateral sclerosis in Texas, 1998\u20132003. Tex. Med. 108(5), e1 (2012)","journal-title":"Tex. Med."},{"key":"1328_CR55","unstructured":"Orphanet Report Series: prevalence of rare diseases: Bibliographic data-May 2012-Number 1  (2012).http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence_of_rare_diseases_by_alphabetical_list.pdf. Accessed June 2020"},{"key":"1328_CR56","unstructured":"ALS Society of Ontario: What is ALS? (2006) http:\/\/www.alsont.ca\/what_is_als.aspx. Accessed 20 Jun 2006"},{"issue":"4","key":"1328_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1600-0404.1996.tb07063.x","volume":"94","author":"S Alcaz","year":"1996","unstructured":"Alcaz, S., Jarebinski, M., Pekmezovic, T., Stevic-Marinkovic, Z., Pavlovic, S., Apostolski, S.: Epidemiological and clinical characteristics of ALS in Belgrade Yugoslavia. Acta. Neurol. Scand. 94(4), 264\u2013268 (1996). https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb07063.x","journal-title":"Acta. Neurol. Scand."},{"key":"1328_CR58","unstructured":"Orphanet Report Series: prevalence of rare diseases: Bibliographic data-May 2011-Number 1 (2011). http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence_of_rare_diseases_by_alphabetical_list.pdf."},{"issue":"1\u20132","key":"1328_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0022-510x(01)00630-x","volume":"191","author":"PM Worms","year":"2001","unstructured":"Worms, P.M.: The epidemiology of motor neuron diseases: a review of recent studies. J. Neurol. Sci. 191(1\u20132), 3\u20139 (2001). https:\/\/doi.org\/10.1016\/s0022-510x(01)00630-x","journal-title":"J. Neurol. Sci."},{"issue":"14","key":"1328_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","volume":"76","author":"M Elamin","year":"2011","unstructured":"Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N., Hardiman, O.: Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76(14), 1263\u20131269 (2011). https:\/\/doi.org\/10.1212\/WNL.0b013e318214359f","journal-title":"Neurology"},{"issue":"6","key":"1328_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/17482960701500817","volume":"8","author":"PH Gordon","year":"2007","unstructured":"Gordon, P.H., Wang, Y., Doorish, C., Lewis, M., Battista, V., Mitsumoto, H., Marder, K.: A screening assessment of cognitive impairment in patients with ALS. Amyotroph. Lateral. Scler. 8(6), 362\u2013365 (2007). https:\/\/doi.org\/10.1080\/17482960701500817","journal-title":"Amyotroph. Lateral. Scler."},{"issue":"3\u20134","key":"1328_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong, M.J., Abrahams, S., Goldstein, L.H., Woolley, S., McLaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobaGyi, T., Rosenfeld, J., Silani, V., Ince, P.G., Turner, M.R.: Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 18(3\u20134), 153\u2013174 (2017). https:\/\/doi.org\/10.1080\/21678421.2016.1267768","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"key":"1328_CR63","unstructured":"Oecd: Health spending. https:\/\/data.oecd.org\/healthres\/health-spending.htm. Accessed June 2020"},{"key":"1328_CR64","unstructured":"World Health Organization: The impact of health expenditure on households and options for alternative financing (No. EM\/RC51\/4) (2004)"},{"key":"1328_CR65","unstructured":"World Health Organization: Global spending on health: a World in Transition. No. WHO\/HIS\/HGF\/HFWorkingPaper\/19.4 (2019)"},{"key":"1328_CR66","unstructured":"Oecd: Average wages (2020)"},{"issue":"8","key":"1328_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","volume":"29","author":"A Larg","year":"2011","unstructured":"Larg, A., Moss, J.R.: Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics 29(8), 653\u2013671 (2011). https:\/\/doi.org\/10.2165\/11588380-000000000-00000","journal-title":"Pharmacoeconomics"},{"issue":"24","key":"1328_CR68","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1212\/WNL.0000000000004038","volume":"88","author":"JPK Rooney","year":"2017","unstructured":"Rooney, J.P.K., Brayne, C., Tobin, K., Logroscino, G., Glymour, M.M., Hardiman, O.: Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology 88(24), 2321\u20132329 (2017). https:\/\/doi.org\/10.1212\/WNL.0000000000004038. (Epub 2017 May 17)","journal-title":"Neurology"},{"issue":"10","key":"1328_CR69","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","volume":"82","author":"MH Huisman","year":"2011","unstructured":"Huisman, M.H., de Jong, S.W., van Doormaal, P.T., Weinreich, S.S., Schelhaas, H.J., van der Kooi, A.J., de Visser, M., Veldink, J.H., van den Berg, L.H.: Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J. Neurol. Neurosurg. Psychiatry. 82(10), 1165\u20131170 (2011). https:\/\/doi.org\/10.1136\/jnnp.2011.244939. (Epub 2011 May 27)","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"3","key":"1328_CR70","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1212\/wnl.52.3.504","volume":"52","author":"BJ Traynor","year":"1999","unstructured":"Traynor, B.J., Codd, M.B., Corr, B., Forde, C., Frost, E., Hardiman, O.: Incidence and prevalence of ALS in Ireland, 1995\u20131997: a population-based study. Neurology 52(3), 504\u2013509 (1999). https:\/\/doi.org\/10.1212\/wnl.52.3.504","journal-title":"Neurology"},{"issue":"14","key":"1328_CR71","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","volume":"368","author":"MD Hurd","year":"2013","unstructured":"Hurd, M.D., Martorell, P., Delavande, A., Mullen, K.J., Langa, K.M.: Monetary costs of dementia in the United States. N. Engl. J. Med. 368(14), 1326\u20131334 (2013). https:\/\/doi.org\/10.1056\/NEJMsa1204629","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"1328_CR72","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal, S.L., Dall, T.M., Chakrabarti, R., Storm, M.V., Jain, A.: The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov. Disord. 28(3), 311\u2013318 (2013). https:\/\/doi.org\/10.1002\/mds.25292. (Epub 2013 Feb 21)","journal-title":"Mov. Disord."},{"key":"1328_CR73","doi-asserted-by":"publisher","first-page":"852368","DOI":"10.1155\/2013\/852368","volume":"2013","author":"N Costa","year":"2013","unstructured":"Costa, N., Ferlicoq, L., Derumeaux-Burel, H., Rapp, T., Garnault, V., Gillette-Guyonnet, S., Andrieu, S., Vellas, B., Lamure, M., Grand, A., Molinier, L.: Comparison of informal care time and costs in different age-related dementias: a review. Biomed. Res. Int. 2013, 852368 (2013). https:\/\/doi.org\/10.1155\/2013\/852368. (Epub 2012 Dec 5)","journal-title":"Biomed. Res. Int."},{"issue":"1\u20132","key":"1328_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/21678421.2014.951946","volume":"16","author":"M Obermann","year":"2015","unstructured":"Obermann, M., Lyon, M.: Financial cost of amyotrophic lateral sclerosis: a case study. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 16(1\u20132), 54\u201357 (2015). https:\/\/doi.org\/10.3109\/21678421.2014.951946. (Epub 2014 Sep 23)","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"issue":"2","key":"1328_CR75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1212\/wnl.43.2.438","volume":"43","author":"AH Moss","year":"1993","unstructured":"Moss, A.H., Casey, P., Stocking, C.B., Roos, R.P., Brooks, B.R., Siegler, M.: Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology 43(2), 438\u2013443 (1993). https:\/\/doi.org\/10.1212\/wnl.43.2.438","journal-title":"Neurology"},{"issue":"4","key":"1328_CR76","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1136\/bmjspcare-2015-001057","volume":"9","author":"NH Anderson","year":"2019","unstructured":"Anderson, N.H., Gluyas, C., Mathers, S., Hudson, P., Ugalde, A.: \u201cA monster that lives in our lives\u201d: experiences of caregivers of people with motor neuron disease and identifying avenues for support. BMJ. Support. Palliat. Care. 9(4), e27 (2019). https:\/\/doi.org\/10.1136\/bmjspcare-2015-001057","journal-title":"BMJ. Support. Palliat. Care."},{"issue":"4","key":"1328_CR77","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/17482968.2010.487532","volume":"11","author":"DJ Oliver","year":"2010","unstructured":"Oliver, D.J., Turner, M.R.: Some difficult decisions in ALS\/MND. Amyotroph. Lateral. Scler. 11(4), 339\u2013343 (2010). https:\/\/doi.org\/10.3109\/17482968.2010.487532","journal-title":"Amyotroph. Lateral. Scler."},{"issue":"3","key":"1328_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/146608201753275517","volume":"2","author":"GD Borasio","year":"2001","unstructured":"Borasio, G.D., Shaw, P.J., Hardiman, O., Ludolph, A.C., Sales Luis, M.L., Silani, V., ALSSG European: Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph. Lateral. Scler. Other. Motor. Neuron. Disord. 2(3), 159\u2013164 (2001). https:\/\/doi.org\/10.1080\/146608201753275517","journal-title":"Amyotroph. Lateral. Scler. Other. Motor. Neuron. Disord."},{"issue":"1","key":"1328_CR79","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/14660820310016615","volume":"5","author":"D Oliver","year":"2004","unstructured":"Oliver, D.: Ventilation in motor neuron disease: difficult decisions in difficult circumstances. Amyotroph. Lateral. Scler. Other. Motor. Neuron. Disord. 5(1), 6\u20138 (2004). https:\/\/doi.org\/10.1080\/14660820310016615","journal-title":"Amyotroph. Lateral. Scler. Other. Motor. Neuron. Disord."},{"key":"1328_CR80","volume-title":"Grundformen gesundheits\u00f6konomischer Evaluationen","year":"2012","unstructured":"Sch\u00f6ffski, O. (ed.): Grundformen gesundheits\u00f6konomischer Evaluationen, 4th edn. Springer, Berlin (2012)","edition":"4"},{"issue":"5","key":"1328_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/OAJCT.S34419","volume":"2013","author":"F Song","year":"2013","unstructured":"Song, F., Hooper, L., Loke, Y.K.: Publication bias: what is it? How do we measure it? How do we avoid it? Open. Access. J. Clin. Trials. 2013(5), 71\u201381 (2013)","journal-title":"Open. Access. J. Clin. Trials."},{"issue":"3","key":"1328_CR82","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","volume":"86","author":"R Rosenthal","year":"1979","unstructured":"Rosenthal, R.: The \u201cfile drawer problem\u201d and tolerance for null results. Psychol. Bull. 86(3), 638\u2013641 (1979)","journal-title":"Psychol. Bull."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-021-01328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-021-01328-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-021-01328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T10:40:01Z","timestamp":1634726401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-021-01328-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1007\/s10198-021-01328-7","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}